Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 2/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.49 |
| ▸ | ESRRG | P62508 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28888658 | 0.92 | OPRK1 (0.55) | OPRK1SIGMAR1ESRRGTSHRLMNA | |
| Bromide SCHEMBL28888657 | 0.91 | OPRK1 (0.54) | OPRK1SIGMAR1ESRRGTSHRLMNA | |
| SCHEMBL5082438 | 0.91 | SIGMAR1 (0.53) | OPRK1SIGMAR1MEN1KMT2ATSHR | |
| SCHEMBL5082809 | 0.85 | KMT2A (0.48) | OPRK1SIGMAR1MEN1KMT2ATSHR | |
| SCHEMBL5076500 | 0.85 | MAOB (0.56) | SIGMAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5082286 | 0.85 | MAOB (0.56) | SIGMAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3050802 | 0.85 | KMT2A (0.51) | OPRK1SIGMAR1MEN1KMT2AGRIN2B | |
| SCHEMBL3052442 | 0.85 | KMT2A (0.51) | OPRK1SIGMAR1MEN1KMT2AGRIN2B | |
| SCHEMBL3052726 | 0.85 | KMT2A (0.51) | OPRK1SIGMAR1MEN1KMT2AGRIN2B | |
| Bromide SCHEMBL5078347 | 0.84 | MAOB (0.55) | SIGMAR1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7408084-B2 | Process for producing optically active β-amino alcohol | KANEKA CORPORATION (JP) | 2008-08-05 | — | — | US | disclosed |
| US-20050277791-A1 | Process for producing optically active beta-amino alcohol | KANEKA CORPORATION (JP) | 2005-12-15 | — | — | US | disclosed |
| EP-1512677-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE s-AMINO ALCOHOL | KANEKA CORPORATION (JP) | 2005-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277791-A1 | Process for producing optically active beta-amino alcohol | ADH1A, ALDH7A1, ADH1C | OPRK1 21/4885SIGMAR1 551/4885ESRRG 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.